A Phase 1b Study of QX1206 in T2DM Patients With NAFLD
A Phase 1b Study of QX1206 in T2DM Patients With NAFLD
Recruiting · NCT06694935 · Registry updated 2025-01-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 1b Study of QX1206 in T2DM Patients With NAFLD | Digestive System Diseases, Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, fatty liver disease, glucose metabolism disease, liver disorder, metabolic disease, metabolic dysfunction-associated steatotic liver disease, type 2 diabetes mellitus | Recruiting | Phase 1 | 2025-01-13 | NCT06694935 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| 1Globe Health Institute | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centricity Research Toronto LMC. | Toronto | Canada | 1 |